Investing Profile

Volker Berl(1)

InvestorAngelFounderCEO
Founder, Managing Partner & CEO at New Age Ventures
newageventures.netNew York, New York
Photo of Volker Berl, Managing Partner at New Age Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Stanford University Network
925 CONNECTIONS
Stanford University Network
925 CONNECTIONS
Eidgenössische Technische Hochschule Zürich Network
38 CONNECTIONS
ETH Zürich Network
31 CONNECTIONS
Concordia University Network
28 CONNECTIONS
cb
New Age Ventures Managing Partner
$100K - $2.0M
$300K
26
CompanyStageDateRound SizeTotal Raised
Opterion Health AG
SeedSep 2023$6.5M
$13M
Koios Medical
Series BFeb 2023$8M
$8M
Annex
Series ADec 2022$500K
$500K
Tabella
Pre Seed Dec 2022$2.5M
Pre-SeedFeb 2021$750K
$3.3M
Co-investors: Joshua Baer (iCiDIGITAL), Zaharo Tsekouras (New Age Ventures)
FemSelect
Series BSep 2022$5.1M
$5.1M
Co-investors: Zaharo Tsekouras (New Age Ventures), Pitou Devgon (Robin Hood Ventures), Daniel Rothman
NewIV Medical
Series AJul 2022
$2M
Aqualung Carbon Capture
Series AMay 2022$10M
$10M
Spruce
Series B ConvertibleDec 2021$4M
$82M
Co-investors: Ken Deeter (Electric Capital), Chris Dixon (Andreessen Horowitz), Malte Barth (BITKRAFT Ventures), Jaynti Kanani (Polygon), Zak Schwarzman (MetaProp Ventures), Andrew White (Mercury Fund), Ejaaz Ahamadeen (Hartmann Capital), Scott Belsky (capitalB), Wes Barton (Third Prime), Joseph Lubin (Ethereal Ventures), Yun-Fang Juan (Brighter Capital), Keith Hamlin (Third Prime), Jutta Steiner, Maya Zehavi, Teck Chia, Matias Woloski
Member of the Board of Directors FemSelect2022 - Present
Member of the Board of Directors, Member of the Governance (Chair), Audit, Compensation Committees Standard Lithium2021 - Present
Member of the Board of Directors Artract2021 - Present
Executive Director Emoshape2020 - Present
Advisor BrainCheck2017 - Present
Member of the Board of Directors Venock2017 - Present
Founder, Managing Partner & CEO New Age Ventures2009 - Present
Member of the Board of Directors Gaussin2007 - Present
Member of the Board of Directors, Member of the Audit Committee OrthogenRxPresent
Member of the Board of Directors Venock MedicalPresent
Executive Director MetaSoul INCPresent
Member of the Board of Directors Artract Medical Inc.Present
Member of the Board of Directors, Chair Governance Committee, Member Audit & Compensation Committees Standard LithiumPresent
Member of the Board of Directors, Audit Committee Chair FTAC Zeus Acquisition CorpPresent
Earn-Out Committee Member OrthogenRxPresent
Member of the Board of Directors, Audit Committee OrthogenRxPresent
Member of the Board of Directors, Audit Committee Chair FTAC Zeus Acquisition Corp.2021 - 2023
Member of the Board of Directors, Audit Committee Member OrthogenRx2017 - 2022
Strategic Advisor Standard Lithium2020 - 2021
Chief Technology Officer ZYMES2006 - 2009
VP Equity Research Deutsche Bank AG2006
Global Business Development BASF AG2002 - 2005
Karlsruher Institut für Technologie (KIT) B.Sc. General Chemistry
Karlsruhe Institute of Technology (KIT) B.Sc., General Chemistry General Chemistry
ECPM Ecole européenne de chimie polymères et matériaux de Strasbourg Ingénieur Chemistry and Chemical Engineering
ETH Zürich M.Sc. Organic Chemistry
Eidgenössische Technische Hochschule Zürich M.Sc. Organic Chemistry
Université de STRASBOURG Ph.D. Supramolecular Chemistry
University of Strasbourg Ph.D. Supramolecular Chemistry
Stanford University Post-Doc Synthetic Organic Chemistry
Concordia University M.B.A. (Executive) Business Administration, General Management
Karlsruhe Institute of Technology (KIT) B.Sc. Chemistry
ECPM Strasbourg, France Engineer Chemical Engineering
ETH Zurich M.Sc. Organic Chemistry
Strasbourg University, France Ph.D. Supramolecular Chemistry
Concordia University M.B.A. General Management
Stanford University Post Ph.D. Organic Chemistry